
Loading, please wait...

Loading, please wait...

A systematic review and meta-analysis compared EBUS-TBNA with surgical mediastinoscopy for mediastinal lymph-node staging in lung cancer. The analysis found that EBUS-TBNA provides high diagnostic accuracy and can be used as an initial invasive staging test in many patients, with surgical approaches reserved for selected cases where the endoscopic result is nondiagnostic or insufficient for the clinical question. The value of the paper is practical: it supports an increasingly less invasive diagnostic pathway without sacrificing the core goal of accurate staging. In a multidisciplinary setting, this can shorten the path from imaging to tissue diagnosis and treatment planning. The findings also underscore the importance of operator experience, appropriate target selection, and a clear escalation strategy when sampling is negative but suspicion remains high. The evidence fits the conference’s repeated focus on EBUS, first-line staging, and the development of a stronger MDT habit. For clinicians in non-metro settings, the broader lesson is that establishing a reliable EBUS program can materially improve the local diagnostic pathway when expertise, pathology support, and referral links are built together.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A systematic review and meta-analysis compared EBUS-TBNA with surgical mediastinoscopy for mediastinal lymph-node staging in lung cancer. The analysis found that EBUS-TBNA provides high diagnostic accuracy and can be used as an initial invasive staging test in many patients, with surgical approaches reserved for selected cases where the endoscopic result is nondiagnostic or insufficient for the clinical question. The value of the paper is practical: it supports an increasingly less invasive diagnostic pathway without sacrificing the core goal of accurate staging. In a multidisciplinary setting, this can shorten the path from imaging to tissue diagnosis and treatment planning. The findings also underscore the importance of operator experience, appropriate target selection, and a clear escalation strategy when sampling is negative but suspicion remains high. The evidence fits the conference’s repeated focus on EBUS, first-line staging, and the development of a stronger MDT habit. For clinicians in non-metro settings, the broader lesson is that establishing a reliable EBUS program can materially improve the local diagnostic pathway when expertise, pathology support, and referral links are built together.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back